Related Experiment Video
Updated: Jun 14, 2026
07:09
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Heart failure with preserved ejection fraction: pathophysiology and emerging therapies
Aaron M From1, Barry A Borlaug
1Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Mayo Foundation, Rochester, MN, USA.
Cardiovascular Therapeutics
|April 8, 2010
Summary
Heart failure with preserved ejection fraction (HFpEF) affects many patients, yet effective treatments remain elusive. This review explores HFpEF
Area of Science:
- Cardiology
- Translational Medicine
Background:
- Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 50% of heart failure cases.
- HFpEF shares similar morbidity and mortality rates with heart failure with reduced ejection fraction (HFrEF).
- Established HFrEF therapies lack proven efficacy in HFpEF, highlighting a critical treatment gap.
Purpose of the Study:
- To review the complex pathophysiology of HFpEF beyond diastolic dysfunction.
- To analyze current clinical trial data for HFpEF treatments.
- To explore emerging investigational therapies for HFpEF.
Main Methods:
- Literature review of pathophysiologic mechanisms in HFpEF.
- Analysis of published clinical trial outcomes for HFpEF.
- Survey of ongoing and upcoming clinical trials for novel HFpEF therapies.
Main Results:
- HFpEF pathophysiology is more complex than initially understood, involving multiple systems.
- Traditional HF treatments show limited efficacy in HFpEF.
- Novel therapeutic strategies are under investigation.
Conclusions:
- A deeper understanding of HFpEF pathophysiology is crucial for developing effective treatments.
- New therapeutic avenues are emerging for HFpEF management.
- Ongoing research holds promise for improving outcomes in HFpEF patients.
Related Concept Videos
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.